BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19127101)

  • 1. Effects of symptom reduction and psychotropic medication on cognitive impairment in depression.
    Frasch K; Bullacher C; Jäger M; Kilian R; Rink M; Wittek R; Becker T; Neumann NU
    Psychopathology; 2009; 42(1):59-66. PubMed ID: 19127101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term stability of cognitive impairment in bipolar disorder: a 2-year follow-up study of lithium-treated euthymic bipolar patients.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    J Clin Psychiatry; 2008 May; 69(5):712-9. PubMed ID: 18435565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern and course of cognitive impairment in late-life depression.
    Köhler S; Thomas AJ; Barnett NA; O'Brien JT
    Psychol Med; 2010 Apr; 40(4):591-602. PubMed ID: 19656429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and course of neuropsychological deficits in manic and depressed bipolar patients compared to patients with Major Depression.
    Gruber S; Rathgeber K; Bräunig P; Gauggel S
    J Affect Disord; 2007 Dec; 104(1-3):61-71. PubMed ID: 17360041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do cognitive deficits in depressive disorders remit?].
    Frasch K; Bretschneider S; Bullacher C; Hess R; Wittek R; Neumann NU
    Psychiatr Prax; 2000 Sep; 27(6):291-5. PubMed ID: 11050736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental evidence for a motivational origin of cognitive impairment in major depression.
    Scheurich A; Fellgiebel A; Schermuly I; Bauer S; Wölfges R; Müller MJ
    Psychol Med; 2008 Feb; 38(2):237-46. PubMed ID: 18005498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and motor features in elderly people with bipolar disorder.
    Martino DJ; Igoa A; Marengo E; Scápola M; Ais ED; Strejilevich SA
    J Affect Disord; 2008 Jan; 105(1-3):291-5. PubMed ID: 17573121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis.
    Reppermund S; Ising M; Lucae S; Zihl J
    Psychol Med; 2009 Apr; 39(4):603-14. PubMed ID: 18667101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study.
    Elgamal S; McKinnon MC; Ramakrishnan K; Joffe RT; MacQueen G
    Psychol Med; 2007 Sep; 37(9):1229-38. PubMed ID: 17610766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
    Johnson FR; Ozdemir S; Manjunath R; Hauber AB; Burch SP; Thompson TR
    Med Care; 2007 Jun; 45(6):545-52. PubMed ID: 17515782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma.
    Savitz JB; van der Merwe L; Stein DJ; Solms M; Ramesar RS
    Bipolar Disord; 2008 Jun; 10(4):479-94. PubMed ID: 18452444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of clinical and neuropsychological variables on the psychosocial and occupational outcome of remitted bipolar patients.
    Mur M; Portella MJ; Martinez-Aran A; Pifarre J; Vieta E
    Psychopathology; 2009; 42(3):148-56. PubMed ID: 19276630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.
    Bora E; Yucel M; Pantelis C
    J Affect Disord; 2009 Feb; 113(1-2):1-20. PubMed ID: 18684514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in insight among patients with bipolar I disorder: a 2-year prospective study.
    Yen CF; Chen CS; Ko CH; Yen JY; Huang CF
    Bipolar Disord; 2007 May; 9(3):238-42. PubMed ID: 17430298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of self-stigma, insight, and perceived adverse effects of medication for the clinical outcomes in patients with depressive disorders.
    Yen CF; Lee Y; Tang TC; Yen JY; Ko CH; Chen CC
    J Nerv Ment Dis; 2009 Mar; 197(3):172-7. PubMed ID: 19282683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cognitive function and clinical and functional outcomes in major depressive disorder.
    Withall A; Harris LM; Cumming SR
    Psychol Med; 2009 Mar; 39(3):393-402. PubMed ID: 18533056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance.
    Allard J; Artero S; Ritchie K
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):874-8. PubMed ID: 14533119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic drug use and cognitive decline among older men and women.
    Dealberto MJ; Mcavay GJ; Seeman T; Berkman L
    Int J Geriatr Psychiatry; 1997 May; 12(5):567-74. PubMed ID: 9193967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.